English

Hong Kong Pharma Digital Technology Holdings Limited

EDGAR

HKPD Report (type unavailable) · filed 2026-09-24

Annual consolidated revenue for 2026: about USD 13.43M, using the latest reported figures. The previous period, 2025, was about USD 20.31M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest fiscal year

Revenue

13.4 million USD

2026 · USD

Exact inputs and evidence

Revenue: 13433507 USD Source

Operating margin

-17.77%

2026 · %

Exact inputs and evidence

Operating Income: -2386538 USD Source
Revenue: 13433507 USD Source

Operating cash flow

-800 thousand USD

2026 · USD

Exact inputs and evidence

Operating Cash Flow: -800000 USD Source

Free cash flow

-835 thousand USD

2026 · USD

Exact inputs and evidence

Operating Cash Flow: -800000 USD Source
Capital Expenditure: 35470 USD Source

Cash and cash equivalents: 222 thousand USD 2026-03-31 Source
Exact value

221841 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-09-24.

Financial data available through: 2026-03-31.

Coverage by financial measure

Revenue: 4 of 11 periods available· newest 2026-03-31
Operating income: 4 of 11 periods available· newest 2026-03-31
Net income: 4 of 11 periods available· newest 2026-03-31
Operating cash flow: 4 of 11 periods available· newest 2026-03-31
Capital expenditure: 4 of 11 periods available· newest 2026-03-31
Total assets: 3 of 11 periods available· newest 2026-03-31
Total liabilities: 3 of 11 periods available· newest 2026-03-31
Current assets: 3 of 11 periods available· newest 2026-03-31
Current liabilities: 3 of 11 periods available· newest 2026-03-31
Cash and cash equivalents: 3 of 11 periods available· newest 2026-03-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-33.9%

Prior period

USD 20.31 million

2024-04-01 – 2025-03-31
Current period

USD 13.43 million

2025-04-01 – 2026-03-31

Exact inputs and evidence

13433507 − 20313818 = -6880311 USD

20313818 USD · 2024-04-01 – 2025-03-31
Inspect prior input Prior source
13433507 USD · 2025-04-01 – 2026-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Hong Kong Pharma Digital Technology Holdings Limited · 2026-03-31 Hong Kong Pharma Digital Technology Holdings Limited (edgar:2007702) Year-over-year change in Revenue: -6880311 USD Concept: fundies:Revenue Period: 2025-04-01 to 2026-03-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/2007702?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 13433507 USD (2025-04-01 to 2026-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2007702/000121390026086725/ea0299789-20f_cellyan.htm#1479440 Filing: 000121390026086725 Input fundies:Revenue: 20313818 USD (2024-04-01 to 2025-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2007702/000121390026086725/ea0299789-20f_cellyan.htm#1479852 Filing: 000121390026086725
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 1.07 million

Prior period

−USD 27,056

2024-04-01 – 2025-03-31
Current period

−USD 1.1 million

2025-04-01 – 2026-03-31

Exact inputs and evidence

-1100000 − -27056 = -1072944 USD

-27056 USD · 2024-04-01 – 2025-03-31
Inspect prior input Prior source
-1100000 USD · 2025-04-01 – 2026-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Hong Kong Pharma Digital Technology Holdings Limited · 2026-03-31 Hong Kong Pharma Digital Technology Holdings Limited (edgar:2007702) Year-over-year change in Net income: -1072944 USD Concept: fundies:NetIncome Period: 2025-04-01 to 2026-03-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/2007702?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -1100000 USD (2025-04-01 to 2026-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2007702/000121390026086725/ea0299789-20f_cellyan.htm#1302938 Filing: 000121390026086725 Input fundies:NetIncome: -27056 USD (2024-04-01 to 2025-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2007702/000121390026086725/ea0299789-20f_cellyan.htm#1075413 Filing: 000121390026086725
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-240.5%

Prior period

USD 569,214

2024-04-01 – 2025-03-31
Current period

−USD 800,000

2025-04-01 – 2026-03-31

Exact inputs and evidence

-800000 − 569214 = -1369214 USD

569214 USD · 2024-04-01 – 2025-03-31
Inspect prior input Prior source
-800000 USD · 2025-04-01 – 2026-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Hong Kong Pharma Digital Technology Holdings Limited · 2026-03-31 Hong Kong Pharma Digital Technology Holdings Limited (edgar:2007702) Year-over-year change in Operating cash flow: -1369214 USD Concept: fundies:OperatingCashFlow Period: 2025-04-01 to 2026-03-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/2007702?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -800000 USD (2025-04-01 to 2026-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2007702/000121390026086725/ea0299789-20f_cellyan.htm#1303204 Filing: 000121390026086725 Input fundies:OperatingCashFlow: 569214 USD (2024-04-01 to 2025-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2007702/000121390026086725/ea0299789-20f_cellyan.htm#1221512 Filing: 000121390026086725
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-49.3%

Prior period

USD 69,916

2024-04-01 – 2025-03-31
Current period

USD 35,470

2025-04-01 – 2026-03-31

Exact inputs and evidence

35470 − 69916 = -34446 USD

69916 USD · 2024-04-01 – 2025-03-31
Inspect prior input Prior source
35470 USD · 2025-04-01 – 2026-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Hong Kong Pharma Digital Technology Holdings Limited · 2026-03-31 Hong Kong Pharma Digital Technology Holdings Limited (edgar:2007702) Year-over-year change in Capital expenditure: -34446 USD Concept: fundies:CapitalExpenditure Period: 2025-04-01 to 2026-03-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/2007702?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 35470 USD (2025-04-01 to 2026-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2007702/000121390026086725/ea0299789-20f_cellyan.htm#1223772 Filing: 000121390026086725 Input fundies:CapitalExpenditure: 69916 USD (2024-04-01 to 2025-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2007702/000121390026086725/ea0299789-20f_cellyan.htm#1224123 Filing: 000121390026086725
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2026 2025-04-01 – 2026-03-31

Revenue USD 13.43 million 100% of revenue
Operating costs Derived USD 15.82 million 118% of revenue
Operating income −USD 2.39 million −18% of revenue
Tax, interest and other Derived −USD 1.29 million −9.6% of revenue
Net income −USD 1.1 million −8.2% of revenue

Cash

Operating cash flow −USD 800,000 −6% of revenue
Capital expenditure USD 35,470 0.3% of revenue
Free cash flow Derived −USD 835,470 −6.2% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2023 Operating loss: operating costs were 114% of revenue.
2024 Operating loss: operating costs were 112% of revenue.
2025 Operating loss: operating costs were 111% of revenue.
2026 Operating loss: operating costs were 118% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2023 2022-04-01 – 2023-03-31	12555991	14347352 Derived	-1791361	-2789557 Derived	998196	1612436 Derived	Source 2022-04-01 – 2023-03-31: 12555991 USD Inspect Revenue Open source 2022-04-01 – 2023-03-31: -1791361 USD Inspect Operating Income Open source 2022-04-01 – 2023-03-31: 998196 USD Inspect Net Income Open source 2022-04-01 – 2023-03-31: 1727079 USD Inspect Operating Cash Flow Open source 2022-04-01 – 2023-03-31: 114643 USD Inspect Capital Expenditure Open source
2024 2023-04-01 – 2024-03-31	16688364	18642806 Derived	-1954442	-3284159 Derived	1329717	-447066 Derived	Source 2023-04-01 – 2024-03-31: 16688364 USD Inspect Revenue Open source 2023-04-01 – 2024-03-31: -1954442 USD Inspect Operating Income Open source 2023-04-01 – 2024-03-31: 1329717 USD Inspect Net Income Open source 2023-04-01 – 2024-03-31: -394330 USD Inspect Operating Cash Flow Open source 2023-04-01 – 2024-03-31: 52736 USD Inspect Capital Expenditure Open source
2025 2024-04-01 – 2025-03-31	20313818	22598405 Derived	-2284587	-2257531 Derived	-27056	499298 Derived	Source 2024-04-01 – 2025-03-31: 20313818 USD Inspect Revenue Open source 2024-04-01 – 2025-03-31: -2284587 USD Inspect Operating Income Open source 2024-04-01 – 2025-03-31: -27056 USD Inspect Net Income Open source 2024-04-01 – 2025-03-31: 569214 USD Inspect Operating Cash Flow Open source 2024-04-01 – 2025-03-31: 69916 USD Inspect Capital Expenditure Open source
2026 2025-04-01 – 2026-03-31	13433507	15820045 Derived	-2386538	-1286538 Derived	-1100000	-835470 Derived	Source 2025-04-01 – 2026-03-31: 13433507 USD Inspect Revenue Open source 2025-04-01 – 2026-03-31: -2386538 USD Inspect Operating Income Open source 2025-04-01 – 2026-03-31: -1100000 USD Inspect Net Income Open source 2025-04-01 – 2026-03-31: -800000 USD Inspect Operating Cash Flow Open source 2025-04-01 – 2026-03-31: 35470 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 13.4M 2026

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20232023-03-31	Revenue	12555991	Revenue: 12555991 Open source
20242024-03-31	Revenue	16688364	Revenue: 16688364 Open source
20252025-03-31	Revenue	20313818	Revenue: 20313818 Open source
20262026-03-31	Revenue	13433507	Revenue: 13433507 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-33.9% 2026

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20232023-03-31	Year over year	No prior comparable period	Revenue: 12555991 Open source
20242024-03-31	Year over year	32.9%	Revenue: 16688364 Open source Revenue: 12555991 Open source
20252025-03-31	Year over year	21.7%	Revenue: 20313818 Open source Revenue: 16688364 Open source
20262026-03-31	Year over year	-33.9%	Revenue: 13433507 Open source Revenue: 20313818 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -17.8% 2026

Net margin -8.2% 2026

Free cash flow margin -6.2% 2026

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20232023-03-31	Operating margin	-14.3%	Operating Income: -1791361 Open source Revenue: 12555991 Open source
20242024-03-31	Operating margin	-11.7%	Operating Income: -1954442 Open source Revenue: 16688364 Open source
20252025-03-31	Operating margin	-11.2%	Operating Income: -2284587 Open source Revenue: 20313818 Open source
20262026-03-31	Operating margin	-17.8%	Operating Income: -2386538 Open source Revenue: 13433507 Open source
20232023-03-31	Net margin	7.9%	Net Income: 998196 Open source Revenue: 12555991 Open source
20242024-03-31	Net margin	8%	Net Income: 1329717 Open source Revenue: 16688364 Open source
20252025-03-31	Net margin	-0.1%	Net Income: -27056 Open source Revenue: 20313818 Open source
20262026-03-31	Net margin	-8.2%	Net Income: -1100000 Open source Revenue: 13433507 Open source
20232023-03-31	Free cash flow margin	12.8%	Revenue: 12555991 Open source Operating Cash Flow: 1727079 Open source Capital Expenditure: 114643 Open source
20242024-03-31	Free cash flow margin	-2.7%	Revenue: 16688364 Open source Operating Cash Flow: -394330 Open source Capital Expenditure: 52736 Open source
20252025-03-31	Free cash flow margin	2.5%	Revenue: 20313818 Open source Operating Cash Flow: 569214 Open source Capital Expenditure: 69916 Open source
20262026-03-31	Free cash flow margin	-6.2%	Revenue: 13433507 Open source Operating Cash Flow: -800000 Open source Capital Expenditure: 35470 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -800K 2026

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20232023-03-31	Operating cash flow	1727079	Operating Cash Flow: 1727079 Open source
20242024-03-31	Operating cash flow	-394330	Operating Cash Flow: -394330 Open source
20252025-03-31	Operating cash flow	569214	Operating Cash Flow: 569214 Open source
20262026-03-31	Operating cash flow	-800000	Operating Cash Flow: -800000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -835.5K 2026

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20232023-03-31	Free cash flow	1612436	Operating Cash Flow: 1727079 Open source Capital Expenditure: 114643 Open source
20242024-03-31	Free cash flow	-447066	Operating Cash Flow: -394330 Open source Capital Expenditure: 52736 Open source
20252025-03-31	Free cash flow	499298	Operating Cash Flow: 569214 Open source Capital Expenditure: 69916 Open source
20262026-03-31	Free cash flow	-835470	Operating Cash Flow: -800000 Open source Capital Expenditure: 35470 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

25.4% 2026

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2023-03-31	Liabilities / assets	Not reported	No source recorded
20242024-03-31	Liabilities / assets	50.9%	Total Liabilities: 4413569 Open source Total Assets: 8667228 Open source
20252025-03-31	Liabilities / assets	47%	Total Liabilities: 4427507 Open source Total Assets: 9417276 Open source
20262026-03-31	Liabilities / assets	25.4%	Total Liabilities: 3261125 Open source Total Assets: 12844248 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

3.86× 2026

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2023-03-31	Current assets / current liabilities	Not reported	No source recorded
20242024-03-31	Current assets / current liabilities	2.46×	Current Assets: 7801710 Open source Current Liabilities: 3176457 Open source
20252025-03-31	Current assets / current liabilities	2.99×	Current Assets: 8727105 Open source Current Liabilities: 2917298 Open source
20262026-03-31	Current assets / current liabilities	3.86×	Current Assets: 12333477 Open source Current Liabilities: 3195850 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2023 2022-04-01 – 2023-03-31	USD 998,196 Exact value Exact value: 998196 USD 2022-04-01 – 2023-03-31: 998196 USD Inspect Net Income Open source Share or cite Citation for Net Income · Hong Kong Pharma Digital Technology Holdings Limited · 2023-03-31 Hong Kong Pharma Digital Technology Holdings Limited (edgar:2007702) Net Income: 998196 USD Concept: fundies:NetIncome Period: 2022-04-01 to 2023-03-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/2007702/explain?concept=fundies%3ANetIncome&period=2023-03-31&surface=latest&period_type=duration&start=2022-04-01&unit=USD&dimensions= Input fundies:NetIncome: 998196 USD (2022-04-01 to 2023-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2007702/000121390025076725/ea0252263-20f_hongkong.htm#870029 Filing: 000121390025076725 The citation records this snapshot. The page link may show a newer release later.	USD 1.73 million Exact value Exact value: 1727079 USD 2022-04-01 – 2023-03-31: 1727079 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Hong Kong Pharma Digital Technology Holdings Limited · 2023-03-31 Hong Kong Pharma Digital Technology Holdings Limited (edgar:2007702) Operating Cash Flow: 1727079 USD Concept: fundies:OperatingCashFlow Period: 2022-04-01 to 2023-03-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/2007702/explain?concept=fundies%3AOperatingCashFlow&period=2023-03-31&surface=latest&period_type=duration&start=2022-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1727079 USD (2022-04-01 to 2023-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2007702/000121390025076725/ea0252263-20f_hongkong.htm#1003224 Filing: 000121390025076725 The citation records this snapshot. The page link may show a newer release later.	USD 114,643 Exact value Exact value: 114643 USD 2022-04-01 – 2023-03-31: 114643 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Hong Kong Pharma Digital Technology Holdings Limited · 2023-03-31 Hong Kong Pharma Digital Technology Holdings Limited (edgar:2007702) Capital Expenditure: 114643 USD Concept: fundies:CapitalExpenditure Period: 2022-04-01 to 2023-03-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/2007702/explain?concept=fundies%3ACapitalExpenditure&period=2023-03-31&surface=latest&period_type=duration&start=2022-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 114643 USD (2022-04-01 to 2023-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2007702/000121390025076725/ea0252263-20f_hongkong.htm#1005693 Filing: 000121390025076725 The citation records this snapshot. The page link may show a newer release later.	USD 1.61 million Calculation and evidence 1727079 − 114643 USD Exact free cash flow: 1612436 USD 2022-04-01 – 2023-03-31: 1727079 USD · Inspect Operating Cash Flow · Source 2022-04-01 – 2023-03-31: 114643 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Hong Kong Pharma Digital Technology Holdings Limited · 2023-03-31 Hong Kong Pharma Digital Technology Holdings Limited (edgar:2007702) Free cash flow: 1612436 USD Concept: free-cash-flow Period: 2022-04-01 to 2023-03-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/2007702?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 1727079 USD (2022-04-01 to 2023-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2007702/000121390025076725/ea0252263-20f_hongkong.htm#1003224 Filing: 000121390025076725 Input fundies:CapitalExpenditure: 114643 USD (2022-04-01 to 2023-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2007702/000121390025076725/ea0252263-20f_hongkong.htm#1005693 Filing: 000121390025076725 The citation records this snapshot. The page link may show a newer release later.
2024 2023-04-01 – 2024-03-31	USD 1.33 million Exact value Exact value: 1329717 USD 2023-04-01 – 2024-03-31: 1329717 USD Inspect Net Income Open source Share or cite Citation for Net Income · Hong Kong Pharma Digital Technology Holdings Limited · 2024-03-31 Hong Kong Pharma Digital Technology Holdings Limited (edgar:2007702) Net Income: 1329717 USD Concept: fundies:NetIncome Period: 2023-04-01 to 2024-03-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/2007702/explain?concept=fundies%3ANetIncome&period=2024-03-31&surface=latest&period_type=duration&start=2023-04-01&unit=USD&dimensions= Input fundies:NetIncome: 1329717 USD (2023-04-01 to 2024-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2007702/000121390026086725/ea0299789-20f_cellyan.htm#1075744 Filing: 000121390026086725 The citation records this snapshot. The page link may show a newer release later.	−USD 394,330 Exact value Exact value: -394330 USD 2023-04-01 – 2024-03-31: -394330 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Hong Kong Pharma Digital Technology Holdings Limited · 2024-03-31 Hong Kong Pharma Digital Technology Holdings Limited (edgar:2007702) Operating Cash Flow: -394330 USD Concept: fundies:OperatingCashFlow Period: 2023-04-01 to 2024-03-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/2007702/explain?concept=fundies%3AOperatingCashFlow&period=2024-03-31&surface=latest&period_type=duration&start=2023-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -394330 USD (2023-04-01 to 2024-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2007702/000121390026086725/ea0299789-20f_cellyan.htm#1222038 Filing: 000121390026086725 The citation records this snapshot. The page link may show a newer release later.	USD 52,736 Exact value Exact value: 52736 USD 2023-04-01 – 2024-03-31: 52736 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Hong Kong Pharma Digital Technology Holdings Limited · 2024-03-31 Hong Kong Pharma Digital Technology Holdings Limited (edgar:2007702) Capital Expenditure: 52736 USD Concept: fundies:CapitalExpenditure Period: 2023-04-01 to 2024-03-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/2007702/explain?concept=fundies%3ACapitalExpenditure&period=2024-03-31&surface=latest&period_type=duration&start=2023-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 52736 USD (2023-04-01 to 2024-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2007702/000121390026086725/ea0299789-20f_cellyan.htm#1224474 Filing: 000121390026086725 The citation records this snapshot. The page link may show a newer release later.	−USD 447,066 Calculation and evidence -394330 − 52736 USD Exact free cash flow: -447066 USD 2023-04-01 – 2024-03-31: -394330 USD · Inspect Operating Cash Flow · Source 2023-04-01 – 2024-03-31: 52736 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Hong Kong Pharma Digital Technology Holdings Limited · 2024-03-31 Hong Kong Pharma Digital Technology Holdings Limited (edgar:2007702) Free cash flow: -447066 USD Concept: free-cash-flow Period: 2023-04-01 to 2024-03-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/2007702?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -394330 USD (2023-04-01 to 2024-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2007702/000121390026086725/ea0299789-20f_cellyan.htm#1222038 Filing: 000121390026086725 Input fundies:CapitalExpenditure: 52736 USD (2023-04-01 to 2024-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2007702/000121390026086725/ea0299789-20f_cellyan.htm#1224474 Filing: 000121390026086725 The citation records this snapshot. The page link may show a newer release later.
2025 2024-04-01 – 2025-03-31	−USD 27,056 Exact value Exact value: -27056 USD 2024-04-01 – 2025-03-31: -27056 USD Inspect Net Income Open source Share or cite Citation for Net Income · Hong Kong Pharma Digital Technology Holdings Limited · 2025-03-31 Hong Kong Pharma Digital Technology Holdings Limited (edgar:2007702) Net Income: -27056 USD Concept: fundies:NetIncome Period: 2024-04-01 to 2025-03-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/2007702/explain?concept=fundies%3ANetIncome&period=2025-03-31&surface=latest&period_type=duration&start=2024-04-01&unit=USD&dimensions= Input fundies:NetIncome: -27056 USD (2024-04-01 to 2025-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2007702/000121390026086725/ea0299789-20f_cellyan.htm#1075413 Filing: 000121390026086725 The citation records this snapshot. The page link may show a newer release later.	USD 569,214 Exact value Exact value: 569214 USD 2024-04-01 – 2025-03-31: 569214 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Hong Kong Pharma Digital Technology Holdings Limited · 2025-03-31 Hong Kong Pharma Digital Technology Holdings Limited (edgar:2007702) Operating Cash Flow: 569214 USD Concept: fundies:OperatingCashFlow Period: 2024-04-01 to 2025-03-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/2007702/explain?concept=fundies%3AOperatingCashFlow&period=2025-03-31&surface=latest&period_type=duration&start=2024-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 569214 USD (2024-04-01 to 2025-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2007702/000121390026086725/ea0299789-20f_cellyan.htm#1221512 Filing: 000121390026086725 The citation records this snapshot. The page link may show a newer release later.	USD 69,916 Exact value Exact value: 69916 USD 2024-04-01 – 2025-03-31: 69916 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Hong Kong Pharma Digital Technology Holdings Limited · 2025-03-31 Hong Kong Pharma Digital Technology Holdings Limited (edgar:2007702) Capital Expenditure: 69916 USD Concept: fundies:CapitalExpenditure Period: 2024-04-01 to 2025-03-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/2007702/explain?concept=fundies%3ACapitalExpenditure&period=2025-03-31&surface=latest&period_type=duration&start=2024-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 69916 USD (2024-04-01 to 2025-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2007702/000121390026086725/ea0299789-20f_cellyan.htm#1224123 Filing: 000121390026086725 The citation records this snapshot. The page link may show a newer release later.	USD 499,298 Calculation and evidence 569214 − 69916 USD Exact free cash flow: 499298 USD 2024-04-01 – 2025-03-31: 569214 USD · Inspect Operating Cash Flow · Source 2024-04-01 – 2025-03-31: 69916 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Hong Kong Pharma Digital Technology Holdings Limited · 2025-03-31 Hong Kong Pharma Digital Technology Holdings Limited (edgar:2007702) Free cash flow: 499298 USD Concept: free-cash-flow Period: 2024-04-01 to 2025-03-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/2007702?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 569214 USD (2024-04-01 to 2025-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2007702/000121390026086725/ea0299789-20f_cellyan.htm#1221512 Filing: 000121390026086725 Input fundies:CapitalExpenditure: 69916 USD (2024-04-01 to 2025-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2007702/000121390026086725/ea0299789-20f_cellyan.htm#1224123 Filing: 000121390026086725 The citation records this snapshot. The page link may show a newer release later.
2026 2025-04-01 – 2026-03-31	−USD 1.1 million Exact value Exact value: -1100000 USD 2025-04-01 – 2026-03-31: -1100000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Hong Kong Pharma Digital Technology Holdings Limited · 2026-03-31 Hong Kong Pharma Digital Technology Holdings Limited (edgar:2007702) Net Income: -1100000 USD Concept: fundies:NetIncome Period: 2025-04-01 to 2026-03-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/2007702/explain?concept=fundies%3ANetIncome&period=2026-03-31&surface=latest&period_type=duration&start=2025-04-01&unit=USD&dimensions= Input fundies:NetIncome: -1100000 USD (2025-04-01 to 2026-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2007702/000121390026086725/ea0299789-20f_cellyan.htm#1302938 Filing: 000121390026086725 The citation records this snapshot. The page link may show a newer release later.	−USD 800,000 Exact value Exact value: -800000 USD 2025-04-01 – 2026-03-31: -800000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Hong Kong Pharma Digital Technology Holdings Limited · 2026-03-31 Hong Kong Pharma Digital Technology Holdings Limited (edgar:2007702) Operating Cash Flow: -800000 USD Concept: fundies:OperatingCashFlow Period: 2025-04-01 to 2026-03-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/2007702/explain?concept=fundies%3AOperatingCashFlow&period=2026-03-31&surface=latest&period_type=duration&start=2025-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -800000 USD (2025-04-01 to 2026-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2007702/000121390026086725/ea0299789-20f_cellyan.htm#1303204 Filing: 000121390026086725 The citation records this snapshot. The page link may show a newer release later.	USD 35,470 Exact value Exact value: 35470 USD 2025-04-01 – 2026-03-31: 35470 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Hong Kong Pharma Digital Technology Holdings Limited · 2026-03-31 Hong Kong Pharma Digital Technology Holdings Limited (edgar:2007702) Capital Expenditure: 35470 USD Concept: fundies:CapitalExpenditure Period: 2025-04-01 to 2026-03-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/2007702/explain?concept=fundies%3ACapitalExpenditure&period=2026-03-31&surface=latest&period_type=duration&start=2025-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 35470 USD (2025-04-01 to 2026-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2007702/000121390026086725/ea0299789-20f_cellyan.htm#1223772 Filing: 000121390026086725 The citation records this snapshot. The page link may show a newer release later.	−USD 835,470 Calculation and evidence -800000 − 35470 USD Exact free cash flow: -835470 USD 2025-04-01 – 2026-03-31: -800000 USD · Inspect Operating Cash Flow · Source 2025-04-01 – 2026-03-31: 35470 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Hong Kong Pharma Digital Technology Holdings Limited · 2026-03-31 Hong Kong Pharma Digital Technology Holdings Limited (edgar:2007702) Free cash flow: -835470 USD Concept: free-cash-flow Period: 2025-04-01 to 2026-03-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/2007702?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -800000 USD (2025-04-01 to 2026-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2007702/000121390026086725/ea0299789-20f_cellyan.htm#1303204 Filing: 000121390026086725 Input fundies:CapitalExpenditure: 35470 USD (2025-04-01 to 2026-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2007702/000121390026086725/ea0299789-20f_cellyan.htm#1223772 Filing: 000121390026086725 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

19 filings · 295 latest values · 295 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0002007702, 2007702, HKPD, edgar:2007702

Also known as CELLYAN BIOTECHNOLOGY CO., LTD, Cellyan Biotechnology Co., Ltd, Hong Kong Pharma Digital Technology Holdings Limited, Hong Kong Pharma Digital Technology Holdings Ltd

Hong Kong Pharma Digital Technology Holdings Limited

Latest fiscal year

Revenue

Operating margin

Operating cash flow

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2026 2025-04-01 – 2026-03-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation